COMMUNIQUÉS West-GlobeNewswire

The Cooper Companies to Participate in the Baird Healthcare Conference
06/08/2019
PLEASANTON, Calif., Aug. 06, 2019 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE: COO) will participate in the Baird 2019 Global Healthcare Conference in New York, NY, on September 4, 2019. Albert G. White III, [...]
Inspire Medical Systems, Inc. Announces Second Quarter 2019 Financial Results and Increases 2019 Outlook
06/08/2019
MINNEAPOLIS, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) ("Inspire"), a medical technology company focused on the development and commercialization of innovative and minimally invasive [...]
Alder BioPharmaceuticals® Reports Second Quarter 2019 Financial and Operating Results
06/08/2019
Data presented at American Academy of Neurology and American Headache Society Annual Meetings continue to support eptinezumab’s differentiated clinical profile and impact on quality of life measures Core commercial [...]
Healthcare Veteran Kristine Johnson to Join MRI Interventions' Board of Directors
06/08/2019
IRVINE, Calif., Aug. 06, 2019 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (NYSE American: MRIC) is pleased to announce that B. Kristine Johnson has been appointed to MRI Interventions’ Board of Directors, effective [...]
Codexis Reports Second Quarter 2019 Financial Results
06/08/2019
Product revenue up 68%; R&D revenue spread over wider base of customers and markets Conference call begins at 4:30 pm Eastern time today REDWOOD CITY, Calif., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq [...]
BioCardia Announces Closing of $10.0 Million Public Offering
06/08/2019
SAN CARLOS, Calif., Aug. 06, 2019 (GLOBE NEWSWIRE) -- BioCardia, Inc. (NasdaqCM: BCDA, BCDAW), a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced the [...]
Prothena Reports Second Quarter 2019 Financial Results and Provides R&D Update
06/08/2019
Net cash used in operating and investing activities was $12.2 million in the second quarter and $29.7 million for the first six months of 2019; quarter-end cash and restricted cash position of $402.2 million provides [...]
Turning Point Therapeutics Reports Second Quarter 2019 Financial and Operational Results
06/08/2019
FDA Accepts Repotrectinib Recommended Phase 2 Dose Regimen for Registrational TRIDENT-1 Study Two Abstracts Selected for Presentation at the European Society for Medical Oncology (ESMO) Annual Congress Highlighting [...]
MRI Interventions Reports 58% Increase in 2019 Second Quarter Revenue
06/08/2019
Record $2.6 Million Quarterly Revenue and Case Volume IRVINE, Calif., Aug. 06, 2019 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (NYSE American: MRIC) (the “Company”) today announced financial results for its second [...]
TCR² Therapeutics to Participate in Upcoming Conferences in August
06/08/2019
CAMBRIDGE, Mass., Aug. 06, 2019 (GLOBE NEWSWIRE) -- TCR 2 Therapeutics Inc. (Nasdaq: TCRR), a clinical-stage immunotherapy company developing the next generation of novel T cell therapies for patients suffering from [...]
ChromaDex Adds Top Talent to its Leadership Team
06/08/2019
Company Names Megan Jordan Chief Communications Officer, Dr. Andrew Shao Global Regulatory Lead, Alberto Bottene Head of Global Sales LOS ANGELES, Aug. 06, 2019 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC), an [...]
Akcea and Ionis Report Top-line Results from the BROADEN Study with WAYLIVRA® (volanesorsen) in Patients with Familial Partial Lipodystrophy
06/08/2019
Study meets primary and key secondary endpoints BOSTON, Mass. and CARLSBAD, Calif., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (NASDAQ: AKCA), an affiliate of Ionis Pharmaceuticals, Inc., and Ionis [...]
Guardant Health Reports Second Quarter 2019 Financial Results and Raises 2019 Revenue Guidance
06/08/2019
Q2 2019 revenue increase of 178% over prior year period REDWOOD CITY, Calif., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on helping conquer cancer [...]
Myovant Sciences Provides Recent Corporate Updates and Reports Financial Results for First Fiscal Quarter Ended June 30, 2019
06/08/2019
-Positive results from both Phase 3 LIBERTY trials and bioequivalence study supports submission of NDA for uterine fibroids which is expected by year end 2019 and MAA which is expected by Q1-2020- -Top-line data from [...]
Myriad to Announce Fiscal Fourth-Quarter 2019 Financial Results on August 13, 2019
06/08/2019
SALT LAKE CITY, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in personalized medicine, today announced that it will hold its fiscal fourth-quarter 2019 sales and earnings conference [...]
Conatus Pharmaceuticals Reports Second Quarter 2019 Financial Results and Program Updates
06/08/2019
SAN DIEGO, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (Nasdaq:CNAT) today announced financial results for the quarter and six months ended June 30, 2019, and provided updates on its development [...]
Xeris Pharmaceuticals Announces Second Quarter 2019 Financial Results and Highlights
06/08/2019
CHICAGO, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ready-to-use [...]
VIVUS Reports Second Quarter 2019 Financial Results
06/08/2019
Company to host conference call today at 4:30pm ET CAMPBELL, Calif., Aug. 06, 2019 (GLOBE NEWSWIRE) -- VIVUS, Inc. (NASDAQ: VVUS) (the “Company”), a specialty pharmaceutical company committed to the development and [...]
SI-BONE, Inc. Reports Second Quarter 2019 Financial Results
06/08/2019
SANTA CLARA, Calif., Aug. 06, 2019 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq:SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today reported financial results [...]

Pages